Clinical Trial Update: A Study to Evaluate the Safety and Antiretroviral Activity of MK-0518 Versus Efavirenz in Treatment Naive HIV-Infected Patients, Each in Combination With TRUVADA (0518-021 EXT) [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing maraviroc (MK-0518) in combination with Truvada to efavirenz-based therapy in treatment-naive HIV-infected patients, assessing safety …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• EFAVIRENZ (efavirenz)
• Maraviroc (maraviroc)
• TRUVADA (EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: HIV Infections | Phase 3 | Status: COMPLETED | Results posted: 2010-05-11